Abstract
BackgroundProgrammed cell death ligand 1 (PD-L1) expressed on tumor and immune cells are both associated with the response to programmed cell death 1 (PD-1) pathway blockade therapy. Here, we examine...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have